![[logo] HealthTree Foundation](https://static.healthtree.org/icons/icon_spinner.svg){kind=icon}
![[logo] HealthTree Foundation](https://static.healthtree.org/logo_icon_only.svg){kind=icon}
Yi-Bin Chen, MD
Director, CML Specialist
Specialities: Hodgkin Lymphoma, Chronic Myeloid Leukemia
Spoken languages: English
%20(1)-min_e83e1827-3fa9-49ea-bb9a-9d9cc83f48ce.jpg?alt=media&token=f0491811-33aa-4961-9907-581660e5f074)
Clinical Expertise
- Chronic Myeloid Leukemia
- Hodgkin's and Non-Hodgkin's lymphoma
About
Dr. Chen is the Director for the BMT program at MGH. His research interests mainly revolve around improving the outcomes for patients undergoing autologous and allogeneic stem cell transplantation. He serves as institution and overall principal investigator for many clinical trials.
Location
Massachusetts General Hospital: 55 Fruit St, Boston, MA 02114, USA
Get the latest thought leadership on your Hodgkin Lymphoma delivered straight to your inbox
Subscribe to the weekly newsletter for news, stories, clinical trial updates, and helpful resources and events with cancer experts.
HealthTree Foundation is a qualified 501(c)(3) tax-exempt organization.
Copyright © 2024 HealthTree Foundation. All rights reserved.
Tax ID 45-5354811